Two cases of successful treatment for severe skin rash induced by vemurafenib following nivolumab therapy without cessation of vemurafenib

J Dermatol. 2017 May;44(5):607-608. doi: 10.1111/1346-8138.13489. Epub 2016 Jun 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Exanthema / chemically induced*
  • Exanthema / prevention & control*
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Melanoma / drug therapy*
  • Nivolumab / administration & dosage*
  • Prednisolone / therapeutic use
  • Proto-Oncogene Proteins B-raf
  • Skin Neoplasms / drug therapy*
  • Vemurafenib / administration & dosage*
  • Vemurafenib / adverse effects

Substances

  • Glucocorticoids
  • Vemurafenib
  • Nivolumab
  • Prednisolone
  • Proto-Oncogene Proteins B-raf